Staar Results 2024 Impact. Evo icl™ continues to outpace refractive industry growth. Gross profit margin for the first quarter of 2024 was 78.9% of net sales compared to the prior year quarter of 78.3% of net sales.
Parents can now access their high school children’s performance results. Provides fiscal 2024 sales outlook of $335 million to $340 million.
Staa), A Leading Developer, Manufacturer And Marketer Of The Evo Family Of Implantable Collamer® Lenses (Evo Icl™) For Myopia, Astigmatism And Presbyopia, Today Announced That It Will Release Financial Results For The First Quarter Ended March 29, 2024, On Tuesday, May 7, 2024,.
Provides fiscal 2024 sales outlook of $335 million to $340 million.
Net Sales Were $77.4 Million For The First Quarter Of 2024, Up 5% Compared To $73.5 Million Reported In The Prior Year Quarter.
Icl sales up 22% in fourth quarter and 18% in fiscal 2023.
“Staar Is Off To A Solid Start In 2024 As Illustrated By Our Preliminary First Quarter Results Including A Record Quarter In The U.s.,” Said Tom Frinzi, President And Ceo Of Staar Surgical.
Images References :
Every Year, Texas Students Take The Staar, And The Results Determine Whether They’ve Met The State’s Academic Standards.
I'm pleased to report staar generated net sales of $77.4 million for the first quarter of 2024, which exceeded our outlook.
Miles Isn’t Rousing Any Marching Bands To Cheer The District’s Most Recent Test Results Just Yet But We Study Them With The Same Caution.
Final assessment results for accountability are available in the family and analytic portals on this date.
Dear Alief Parents, The Texas Education Agency (Tea) Is Providing Access To Your Student’s State Assessment Results Electronically.